All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @itsjessandreasen on TikTok · 61s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @itsjessandreasen's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Okay, what are our peptide stacks and where are we injecting them?
  2. 0:11I, my GHK-Cu, consistently leaves red marks and like swelling and itchy burning like it
  3. 0:20swells up.
  4. 0:21I've tried my belly, my thighs, my hips, my butt.
  5. 0:26I just did my lap today right there.
  6. 0:29We'll see, but it because it's like muscle pain and it gets red, almost like a bad bug
  7. 0:35bite.
  8. 0:36I'm a bit bitchy and I like make my whole arm sore wherever I take it.
  9. 0:40So I'm trying my lats today, but I'm wondering if you take GHK-Cu, where you inject and what
  10. 0:47other peptides are taking.
  11. 0:48I tried NAD and it made me feel very flushed, fatigued, like, blah.
  12. 0:54So I don't know if I need a different dose or whatever, but what's your peptide stack and
  13. 0:58where are you injecting?

@itsjessandreasen's peptide stack video raises red flags

Jess Andreasen

TikTok creator

33.4K viewsWatch on TikTok

Quick answer

The creator is describing recurrent injection site reactions to subcutaneous GHK-Cu administration, characterized by erythema, pruritus, and localized swelling consistent with either a mechanical or immune-mediated response to the peptide or its copper component. She is also reporting systemic side effects from NAD+ administration, including flushing and fatigue, which are known dose-dependent adverse effects documented in clinical trials. Neither compound she references is FDA-approved for injectable use, and both are being used outside a clearly described clinical supervision framework.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @itsjessandreasen's peptide stack video raises red flags, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@itsjessandreasen's peptide stack video raises red flags" from Jess Andreasen. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is describing recurrent injection site reactions to subcutaneous GHK-Cu administration, characterized by erythema, pruritus, and localized swelling consistent with either a mechanical or immune-mediated response to the peptide or its copper component.

The reason this review is not generic is the source wording and the canonical claim label "peptides tell me your peptide stacks and where you inject peptide." In this clip, the useful excerpt is: "Okay, what are our peptide stacks and where are we injecting them?" That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Copper is a documented contact sensitizer (Rietschel and Fowler, 2008, Fisher's Contact Dermatitis), which may contribute to the localized inflammatory reactions the creator describes, though this specific mechanism has not been confirmed for injected GHK-Cu.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is describing recurrent injection site reactions to subcutaneous GHK-Cu administration, characterized by erythema, pruritus, and localized swelling consistent with either a mechanical or immune-mediated response to the peptide or its copper component.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is describing recurrent injection site reactions to subcutaneous GHK-Cu administration, characterized by erythema, pruritus, and localized swelling consistent with either a mechanical or immune-mediated response to the peptide or its copper component. She is also reporting systemic side effects from NAD+ administration, including flushing and fatigue, which are known dose-dependent adverse effects documented in clinical trials. Neither compound she references is FDA-approved for injectable use, and both are being used outside a clearly described clinical supervision framework.
  • GHK-Cu is not FDA-approved as an injectable drug. Human subcutaneous injection safety data is largely absent from peer-reviewed literature, making it difficult to characterize expected side effect profiles.
  • Copper is a documented contact sensitizer (Rietschel and Fowler, 2008, Fisher's Contact Dermatitis), which may contribute to the localized inflammatory reactions the creator describes, though this specific mechanism has not been confirmed for injected GHK-Cu.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu is not FDA-approved as an injectable drug. Human subcutaneous injection safety data is largely absent from peer-reviewed literature, making it difficult to characterize expected side effect profiles.
  • Copper is a documented contact sensitizer (Rietschel and Fowler, 2008, Fisher's Contact Dermatitis), which may contribute to the localized inflammatory reactions the creator describes, though this specific mechanism has not been confirmed for injected GHK-Cu.
  • Flushing and fatigue from NAD+ are real, dose-dependent side effects confirmed in at least two randomized trials (Elhassan et al., 2019, Cell Reports; Dollerup et al., 2018, Cell Metabolism). They are not signs the product is not working.
  • Site rotation reduces localized tissue trauma from repeated injections but will not necessarily resolve reactions that are immune-mediated or driven by the peptide compound itself.
  • There is no published human safety data on stacking multiple injectable peptides simultaneously, which is the practice this video's comments section is soliciting advice about.
  • Compounded peptides sold for injection are not equivalent to pharmaceutical-grade approved drugs. Purity, sterility, and concentration can vary significantly between compounders.
  • Persistent injection site reactions that resemble allergic responses (swelling, redness, pruritus, burning) should be evaluated by a clinician, not managed through social media troubleshooting.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @itsjessandreasen actually say?

She described consistent local reactions after injecting GHK-Cu subcutaneously, including redness, swelling, itching, and burning that she compared to "a bad bug bite." She said she has rotated through her belly, thighs, hips, and glutes trying to find a tolerable site, and was experimenting with her lats on the day of filming. She also mentioned trying NAD (presumably NAD+ infusion or injection) and experiencing flushing and fatigue. No specific doses were mentioned. The video is essentially a community question: where do you inject and what else are you taking?

To be clear, this is anecdote-sharing, not medical advice-giving. She is not claiming GHK-Cu treats any condition, and she is not recommending anyone start it. That framing matters for how we evaluate the content.

Does the science back this up?

Yes, actually. Local injection site reactions with subcutaneous peptide administration are well-documented and not specific to GHK-Cu. The reactions she describes are consistent with what researchers call injection site reactions (ISRs), which can include erythema, pruritus, and induration.

GHK-Cu (copper tripeptide-1) has been studied primarily in wound healing, skin aging, and anti-inflammatory contexts. Pickart et al. (2015, Journal of Aging Science) reviewed GHK-Cu's biological activity extensively but that research was largely topical or in vitro. Human subcutaneous injection data is scarce because GHK-Cu is not an FDA-approved injectable drug. The absence of clinical trial data on subcutaneous injection tolerability is a real gap.

What we do know from broader peptide research: subcutaneous injections of bioactive peptides can cause localized histamine-like responses, particularly when the peptide has copper chelation activity. Copper itself is a known contact sensitizer (Rietschel and Fowler, 2008, Fisher's Contact Dermatitis). That mechanism could partially explain her reaction pattern, though no study has confirmed this specifically for injected GHK-Cu in humans.

What did they get wrong (or right)?

She got the symptom description right: what she is experiencing sounds like a genuine injection site reaction, not a sign she is injecting incorrectly. Rotating sites is the correct instinct and is consistent with standard subcutaneous injection guidance used in insulin and biologic therapy protocols.

Where the video falls short is in assuming that changing the injection site will resolve the reaction. If the reaction is driven by the peptide itself or its copper component, site rotation may reduce localized trauma but is unlikely to eliminate the immune-mediated response. She may be dealing with a sensitivity to the compound, not just poor technique or site fatigue.

Her NAD comment deserves a flag. Flushing and fatigue from NAD+ are common and dose-dependent side effects documented even in clinical settings (Elhassan et al., 2019, Cell Reports). But "I don't know if I need a different dose or whatever" is not a framework for adjusting a biologically active injectable. That kind of titration needs clinical supervision, not a TikTok comment section.

What should you actually know?

A few things worth knowing if you are following peptide therapy content online. First, GHK-Cu is not FDA-approved as an injectable drug. It is available as a research chemical or through compounding pharmacies in some jurisdictions, but compounded formulations are not equivalent to any approved drug and vary in purity and sterility. Second, consistent injection site reactions that look like "a bad bug bite" are worth telling a clinician about. They can indicate a sensitivity that may worsen over time.

Third, the TikTok peptide community frequently discusses stacking multiple peptides simultaneously, which is what the caption is soliciting. There is essentially no human safety data on most peptide combinations. What works for one person's goals and physiology may not translate to another's, and some combinations carry real risks that are not discussed in these formats.

If you are using injectable peptides, they should be prescribed and monitored by a licensed clinician who can assess your specific situation, not crowdsourced from social media.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jess Andreasen · TikTok creator

33.4K views on this video

Tell me your peptide stacks and where you inject? #peptidetok #peptidetherapy #ghkcu #peptide

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu?

GHK-Cu is not FDA-approved as an injectable drug. Human subcutaneous injection safety data is largely absent from peer-reviewed literature, making it difficult to characterize expected side effect profiles.

What does the video say about copper?

Copper is a documented contact sensitizer (Rietschel and Fowler, 2008, Fisher's Contact Dermatitis), which may contribute to the localized inflammatory reactions the creator describes, though this specific mechanism has not been confirmed for injected GHK-Cu.

What does the video say about flushing?

Flushing and fatigue from NAD+ are real, dose-dependent side effects confirmed in at least two randomized trials (Elhassan et al., 2019, Cell Reports; Dollerup et al., 2018, Cell Metabolism). They are not signs the product is not working.

What does the video say about site rotation reduces localized tissue trauma from repeated injections?

Site rotation reduces localized tissue trauma from repeated injections but will not necessarily resolve reactions that are immune-mediated or driven by the peptide compound itself.

What does the video say about there?

There is no published human safety data on stacking multiple injectable peptides simultaneously, which is the practice this video's comments section is soliciting advice about.

What does the video say about compounded peptides sold for injection?

Compounded peptides sold for injection are not equivalent to pharmaceutical-grade approved drugs. Purity, sterility, and concentration can vary significantly between compounders.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jess Andreasen, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.